Evidence map›Paper›PMID 42642410›Full record

ArticleNature communications2026

Polymorphic IGLV6-57 AL amyloid fibrils and features of a shared folding pathway.

Parker T Bassett, Binh A Nguyen, Virender Singh, Patrick T Garrett, James J Moresco, Joshua Eddy, Shumaila Afrin, Maja Pękała, Christian Lopez, Bret M Evers and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Transthyretin amyloid fibrils adopt distinct folds in the brain.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Parker T BassettCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0009-0001-5162-7212
Binh A NguyenCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7055-8809
Virender SinghSciKonnect and BioPatriKa, Ambala, India.ORCID http://orcid.org/0000-0002-6720-8784
Patrick T GarrettDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8434-9693
James J MorescoCenter for the Genetics of Host Defense, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0003-1178-1642
Joshua EddyCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Shumaila AfrinCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Maja PękałaCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Christian LopezDepartment of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0009-0005-1820-0144
Bret M EversDepartment of Pathology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0001-5686-0315
Yasmin AhmedCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Rose PedrettiCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Justin L GrodinDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Lori R RothDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Gurbakhash KaurTisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Stephen ChungDepartment of Internal Medicine, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.ORCID http://orcid.org/0000-0002-1433-7419
Gareth J MorganAmyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1275-2010
John R YatesDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5267-1672
Lorena SaelicesCenter for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA. lorena.saelicesgomez@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-1904-2150

Funding

The Stanford-SLAC CryoEM CenterR24GM154186 · NIGMS · STANFORD UNIVERSITY · PI Wah Chiu, BRITT HEDMAN · 2024 to 2026
$19.3M
Closing the gap between structural biology and translational science for amyloid diseasesDP2HL163810 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAELICES GOMEZ, LORENA · 2021 to 2024
$2.5M
Screening for Cardiac Amyloidosis with a Blood Biomarker in Minority Populations – SCABB-MPR01HL177670 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MATHEW S MAURER, Frederick Lief Ruberg · 2025 to 2026
$970k
TEM for UT Southwestern Electron Microscopy Core FacilityS10OD021685 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI LUBY-PHELPS, KATHERINE J · 2017 to 2017
$398k
NHLBI NIH HHS DP2 HL163810NHLBI NIH HHS R01 HL177670NIGMS NIH HHS R24 GM154186NIH HHS S10 OD021685U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) DP2HL163810U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL177670
6 · The paper itself

Abstract

Immunoglobulin light chain (AL) amyloidosis is a systemic disorder caused by the misfolding and aggregation of free immunoglobulin light chains (LCs) secreted by abnormal plasma cells. The resulting amyloid fibrils deposit in multiple organs, leading to progressive dysfunction and increased morbidity and mortality. Despite recent advances, the molecular determinants of LC aggregation and their effect on phenotypic variability are not fully defined. Structural characterization of ex-vivo fibrils provides insights into the underlying amyloidogenic processes that may affect the downstream pathogenesis. Here, we report cryo-electron microscopy structures of cardiac AL amyloid fibrils derived from an IGLV6-57 light chain. The fibrils display two distinct morphologies composed of single and double protofilaments, each adopting a previously unobserved fold. Comparison with previously reported AL fibril structures reveals that while individual mutations can alter the local conformation, IGLV6-57-derived fibrils share conserved structural motifs that may underlie common aggregation pathways. These findings expand the disease structural landscape and highlight sequence-dependent yet structurally constrained mechanisms of LC fibril formation.

Indexed as

AmyloidImmunoglobulin Light-chain AmyloidosisImmunoglobulin Light ChainsCryoelectron MicroscopyHumansModels, MolecularMutationProtein FoldingAmyloidImmunoglobulin Light Chains

Identifiers

PMID42642410
PMCPMC13507080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.